Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baijayanta Maiti

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Annals of Clinical and Translational Neurology|July 26, 2021
Distinct progression patterns across Parkinson disease clinical subtypesPeter S Myers, Joshua J Jackson, Amber K Clover, et al.
Cerebral Cortex (New York, N.Y. : 1991)|June 8, 2018
Emergent Functional Network Effects in Parkinson DiseaseCaterina Gratton, Jonathan M Koller, William Shannon, et al.
Cerebral Cortex (New York, N.Y. : 1991)|November 13, 2018
Emergent Functional Network Effects in Parkinson DiseaseCaterina Gratton, Jonathan M Koller, William Shannon, et al.
Human Mutation|December 11, 2008
A mutation in the SEPN1 selenocysteine redefinition element (SRE) reduces selenocysteine incorporation and leads to SEPN1-related myopathyBaijayanta Maiti, Sandrine Arbogast, Valérie Allamand, et al.
Clinical Biomechanics (Bristol, Avon)|February 4, 2025
Differential gait features across Parkinson's disease clinical subtypesSidney T Baudendistel, Kerri S Rawson, Christina N Lessov-Schlaggar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 11, 2024
PET Quantification of [<sup>18</sup>F]VAT in Human Brain and Its Test-Retest Reproducibility and Age DependenceJohn L O'Donnell, Anil Kumar Soda, Hao Jiang, et al.
EJNMMI Research|May 14, 2025
Radiation dosimetry of [<sup>11</sup>C]TZ1964B as determined by whole-body PET imaging of nonhuman primatesBaijayanta Maiti, Noah L Goldman, Mahdjoub Hamdi, et al.
Parkinsonism & Related Disorders|June 5, 2024
Replication and reliability of Parkinson's disease clinical subtypesTherese V Cash, Christina N Lessov-Schlaggar, Erin R Foster, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 30, 2020
Is Levodopa Response a Valid Indicator of Parkinson's Disease?W R Wayne Martin, Michael Miles, Qiaonan Zhong, et al.
Human Mutation|December 5, 2013
The ZZ domain of dystrophin in DMD: making sense of missense mutationsAdeline Vulin, Nicolas Wein, Dana M Strandjord, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Annals of Clinical and Translational Neurology|July 26, 2021
Distinct progression patterns across Parkinson disease clinical subtypesPeter S Myers, Joshua J Jackson, Amber K Clover, et al.
Cerebral Cortex (New York, N.Y. : 1991)|June 8, 2018
Emergent Functional Network Effects in Parkinson DiseaseCaterina Gratton, Jonathan M Koller, William Shannon, et al.
Cerebral Cortex (New York, N.Y. : 1991)|November 13, 2018
Emergent Functional Network Effects in Parkinson DiseaseCaterina Gratton, Jonathan M Koller, William Shannon, et al.
Human Mutation|December 11, 2008
A mutation in the SEPN1 selenocysteine redefinition element (SRE) reduces selenocysteine incorporation and leads to SEPN1-related myopathyBaijayanta Maiti, Sandrine Arbogast, Valérie Allamand, et al.
Clinical Biomechanics (Bristol, Avon)|February 4, 2025
Differential gait features across Parkinson's disease clinical subtypesSidney T Baudendistel, Kerri S Rawson, Christina N Lessov-Schlaggar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 11, 2024
PET Quantification of [<sup>18</sup>F]VAT in Human Brain and Its Test-Retest Reproducibility and Age DependenceJohn L O'Donnell, Anil Kumar Soda, Hao Jiang, et al.
EJNMMI Research|May 14, 2025
Radiation dosimetry of [<sup>11</sup>C]TZ1964B as determined by whole-body PET imaging of nonhuman primatesBaijayanta Maiti, Noah L Goldman, Mahdjoub Hamdi, et al.
Parkinsonism & Related Disorders|June 5, 2024
Replication and reliability of Parkinson's disease clinical subtypesTherese V Cash, Christina N Lessov-Schlaggar, Erin R Foster, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 30, 2020
Is Levodopa Response a Valid Indicator of Parkinson's Disease?W R Wayne Martin, Michael Miles, Qiaonan Zhong, et al.
Human Mutation|December 5, 2013
The ZZ domain of dystrophin in DMD: making sense of missense mutationsAdeline Vulin, Nicolas Wein, Dana M Strandjord, et al.
Pageof 3